Infectious virus diseases have significant impacts on public health and emerge at an unprecedented rate. Compare to all viral diseases, combating COVID-19, that is caused by the SARS-CoV-2 virus was a big challenge to the researchers. Among all the therapeutics, antiviral drugs, corticosteroids, and Disease-Modifying Anti-Rheumatic Drugs (DMARDs) occupy a prominent position in declining the COVID-19 mortality rate. With the advent of science and technology, recent clinical studies extended towards the assessment of Multi-Drug Therapy (MDT) impact on invading the pathogen and adverse effects on cellular metabolism. Recent studies showed that MDT also affects major cellular functions such as fertility, however, the interactions of Anti COVID-19 Therapeutics (ACTs) with the fertility-related biomolecules are not yet clear. In the current study, I show the interaction of ACTs such as Dexamethasone, Remdesivir, and Baricitinib with the Homo sapiens acrosomal protein SP-10 using molecular docking studies. Among all the drug interactions with the SP-10 protein structure, Dexamethasone showed the highest binding affinity -5.9, followed by Remdesivir -5.3 and Baricitinib -5.0 kcal/mol. The interaction between ACTs and human SP-10 might help to unveil the fertility issues that arise in males during COVID-19 disease management.